Cuban scientist highlighted progress of vaccine candidate in trial of Soberana Centro

CRUCES, Cienfuegos, Cuba,Aug 24 (ACN) Dr. C. Vicente Verez Bencomo, general director of the Finlay Vaccine Institute (IFV), highlighted in this city(central region ) advances of the Soberana 01 vaccine candidate included in the Soberana Centro clinical trial, which is taking place in the Cruces and Palmira municipalities of the province of Cienfuegos.

In exclusive statements to the Cuban News Agency, Verez Bencomo highlighted that Soberana 01 is giving a very early response in the vaccination, especially in those individuals who respond unfavorably to the rest of the vaccines.

This is phase two -of three stages of the clinical trial- which is being undertaken in Cienfuegos localities and should give us the response of Soberana 01 in relation to the Soberana 02 and Soberana Plus vaccines, and thus will be able to find the space that each one should have in its use, the researcher added.

The trial includes three doses, and started with the inoculation of the first one last July 26 and now, after 28 days, they are applying the second dose of the immunogen.

This research is a randomized, double-blind, parallel-group, adaptive and multicenter study to evaluate the immunogenicity of the anti-SARS-CoV-2 vaccine, the expert concluded.